NEW YORK--(BUSINESS WIRE)--OMRIX Biopharmaceuticals, Inc. (“OMRIX” or the “Company”) (NASDAQ: OMRI), a fully-integrated biopharmaceutical company that develops and markets protein-based biosurgery and passive immunotherapy products, announced today that Michael Burshtine, Executive Vice President and Chief Financial Officer, is scheduled to give a company presentation at the Citigroup Small & Mid-Cap Conference on Tuesday, March 13, 2007 at 11:25 a.m. PT (2:25 p.m. ET) at the Four Seasons Hotel Las Vegas.
